Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  DexCom, Inc.    DXCM

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/19/2017 05/22/2017 05/23/2017 05/24/2017 05/25/2017 Date
67.66(c) 68.85(c) 67.58(c) 68.26(c) 69.15 Last
1 632 226 1 091 354 576 171 855 616 1 040 545 Volume
-1.46% +1.76% -1.84% +1.01% +1.30% Change
More quotes
Financials ($)
Sales 2017 728 M
EBIT 2017 -55,2 M
Net income 2017 -56,4 M
Finance 2017 134 M
Yield 2017 -
Sales 2018 956 M
EBIT 2018 11,5 M
Net income 2018 9,66 M
Finance 2018 202 M
Yield 2018 -
P/E ratio 2017 -
P/E ratio 2018 551,37
EV / Sales2017 7,92x
EV / Sales2018 5,96x
Capitalization 5 896 M
More Financials
Company
DexCom, Inc. is a medical device manufacturing company, which engages in the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes.Its products include Dexcom G4 PLATINUM System, Dexcom studio and Mobile apps.The company was... 
More about the company
Surperformance© ratings of DexCom, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on DEXCOM, INC.
05/15 DEXCOM : Announces Upcoming Conference Presentation
05/12 DEXCOM, INC. (NASDAQ : DXCM) Files An 8-K Entry into a Material Definitive Agree..
05/12 DEXCOM INC : Entry into a Material Definitive Agreement, Creation of a Direct Fi..
05/09 DEXCOM : Prices Offering of $350 Million of 0.75% Convertible Senior Notes
05/08 DEXCOM, INC. (NASDAQ : DXCM) Files An 8-K Other Events
05/08 DEXCOM INC : Other Events, Financial Statements and Exhibits (form 8-K)
05/08 DEXCOM : Announces Proposed Offering of $300 Million of Convertible Senior Notes
05/02 DEXCOM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
05/02 DEXCOM : reports 1Q loss
05/02 DEXCOM INC : Results of Operations and Financial Condition, Regulation FD Disclo..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
05/23DJFirms Persuade SEC on Profit Metric -- WSJ
05/22DJCompanies Are Winning the Battle Over Adjusted Earnings
05/16 Earnings drag on European shares, though Vodafone lifts telcos
05/09 French outbound M&A driven to decade high by big deals
05/06DJProfits Jump, Spending Lags -- WSJ
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
05/25Henderson Group PLC Holds Stake in DexCom, Inc. $DXCM  
05/25Pier Capital LLC Acquires Shares of 3,291 DexCom, Inc. $DXCM  
05/23DexCom $DXCM Receives Coverage Optimism Rating of 0.08  
05/22On The Fly: Top five analyst initiations $AA $FND $VRNA $MDCO $DXCM
3
05/22DexCom, Inc. $DXCM Earns Overweight Rating from Piper Jaffray Companies  
More tweets
Qtime:37
News from SeekingAlpha
05/18 What To Do During A Selloff - Cramer's Mad Money (5/17/17)
05/15 Artificial Pancreas Partnerships Aim To Compete With Medtronic
05/12 Diabeloop Takes The Collaborative Route To Europe
05/03 DEXCOM AND HANESBRANDS : Stock Price Action Being Driven By Speculative Trading
05/02 DexCom (DXCM) Q1 2017 Results - Earnings Call Transcript
Advertisement
Chart DEXCOM, INC.
Duration : Period :
DexCom, Inc. Technical Analysis Chart | DXCM | US2521311074 | 4-Traders
Full-screen chart
Technical analysis trends DEXCOM, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 90,1 $
Spread / Average Target 32%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Kevin Ronald Sayer President, Chief Executive Officer & Director
Terrance H. Gregg Executive Chairman
Jeffrey C. Moy Senior Vice President-Operations
Kevin Sun Chief Financial Officer & Vice President
Jacob Leach Senior Vice President-Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
DEXCOM, INC.14.34%5 947
MEDTRONIC PLC18.78%114 973
BAXTER INTERNATIONAL I..31.57%31 343
ZIMMER BIOMET HOLDINGS..15.41%23 752
C R BARD INC37.29%22 251
HOYA CORPORATION11.85%19 129
More Results